Navigation Links
Insmed Incorporated Provides Regulatory Update
Date:10/10/2011

derstanding of the FDA's requests and their implications, we will provide a further update to the market."

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases, and has a proprietary protein platform aimed at niche markets with high unmet medical need. Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to our financial position, results of operations, the status and the results of preclinical studies and clinical trials and preclinical and clinical data described herein, the timing of responses to information and data requests from FDA, the development of our products, and the business strategies, plans and objectives of management, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements.  Our results may be affected by such factors as the receipt and timing of FDA and other regulatory reviews and approvals, if at all, competitive developments affecting our product development, delays in product development or clinical trials, and patent disputes involving currently developing products.  The risks and uncertainties include, without limitation, we may experience unexpected regulatory actions, delays or requests, our future clinical trials may not be successful, we
'/>"/>

SOURCE Insmed Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
2. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
3. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
4. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
5. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
6. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
7. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
8. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
9. Insmed to Host Third Quarter 2010 Conference Call
10. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010
11. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... 2014 Registreer nu via  http://bit.ly/ag8Sypm14de ... 20. Februar sind alle akkreditierten pharmazeutischen Patientenversorgungsakten-Firmen ... PARTNER PROGRAMM ™ 2015 in ... Diese Tagung soll dazu beitragen, der Aegate ... neue profitablen Unternehmensdienstleistungen, die für Apotheken und ...
(Date:12/15/2014)... 15, 2014 BerGenBio AS, a ... drug resistant cancers, today announces that it has raised ... from new and existing investors. BerGenBio will ... development of its pipeline of innovative cancer therapeutics, in ... drug candidate, BGB324, a first-in-class selective Axl kinase inhibitor, ...
(Date:12/15/2014)... -- Investor-Edge has initiated coverage on the following ... and Company (NYSE: LLY ), Nektar Therapeutics (NASDAQ: ... and Novartis AG (NYSE: NVS ). Free research ... . On Friday, December 12, 2014, the NASDAQ ... Average lost 1.79%, to finish the day at 17,280.83, and ...
Breaking Medicine Technology:Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2BerGenBio Completes NOK90 Million Fundraising 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5
... -- Neuropsychiatric Data from Pivotal Trial Presented at Annual ... American Association for Geriatric Psychiatry ... ,Medivation, Inc. (Nasdaq: MDVN ) today announced that ... that behavioral symptoms were,stabilized in patients with mild-to-moderate Alzheimer,s ...
... Laser Technology gives patients new lease on life, ... facial plastic,surgeon is giving hope to patients suffering from ... FX by Lumenis is a fractional laser procedure performed ... procedure, a,high- energy beam of laser light is used ...
Cached Medicine Technology:Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 2Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 3Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 4Miami Plastic Surgeon Offers Hope to Acne Scarred Patients 2
(Date:12/19/2014)... 2014 (HealthDay News) -- The tragic death from "rat-bite fever" ... by the pet rodents, according to a report from the ... is a rare but potentially fatal illness that should be ... when a history of rodent exposure is reported," said a ... Intelligence Service. The case outlined in the report occurred ...
(Date:12/19/2014)... THURSDAY, Dec. 18, 2014 (HealthDay News) -- Prostaglandin analogue ... -- significantly reduce the risk of vision loss in ... British researchers led by David Garway-Heath, of the ... London, tracked outcomes for more than 500 people newly ... of the disease and one of the leading causes ...
(Date:12/17/2014)... December 17, 2014 Unidesk Corporation ... Medicine (ACOM), which welcomed its inaugural class in ... (VDI) to seamlessly support bring your own device ... teaching – experience. The solution, comprised of ... Dell server and storage infrastructure and ...
(Date:12/17/2014)... In its comprehensive analysis of medical ... Claim Review division have recently identified out-of-network and medical ... savings are achieved on behalf of employer-clients. , ... in savings to Argus each year, with a total ... by Tom Doney, Cypress president and CEO, these in-depth ...
(Date:12/17/2014)... News) -- As gas prices rose in recent years, ... suggests. In times of gas increases, more people ... inexperienced, the researchers explained. They examined data gathered ... highest number of motorcycle registrations in the United States ... The analysis revealed a strong association between rising gas ...
Breaking Medicine News(10 mins):Health News:Scratch From Pet Rat Kills Child; CDC Warns of Risk 2Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2
... ,It,s Totally Glam to Go for a Mammogram, and ... Men ,Don,t Wait to Check Your Prostate, DALLAS, ... across Texas are sending a different kind of love note to ... women can send an e-reminder to,schedule important cancer screenings that will ...
... ... ... it has begun shipping the new SILVER SEAL(TM) Washable, Antimicrobial,Keyboard. According ... keyboard to be fully submersible, dishwasher safe,and manufactured from SILVER SEAL(TM) ...
... ARLINGTON, Va., Feb. 12 As health care,continues ... election, The HealthCentral,Network, Inc.,s ( http://www.HealthCentral.com ) interactive ... credible tool for voters to determine,which candidate aligns ... Now, washingtonpost.com has chosen the tool for its ...
... 12 Thanks to the collective spirit,of three ... new event has been added to the 2008 ... Triathlon, and registration,is now open., The Ramblin, ... empowerment of women, bring together women of all ...
... a,leading provider of evidence-based nutraceuticals for eye health, today,announced ... its Scientific,Advisory Board., Dr. Coleman is a Professor ... David Geffen School of Medicine at UCLA as well ... Health. She holds,the Frances and Ray Stark Endowed Chair ...
... Transitions, ... Feb. 12 In an effort to heighten,consumer awareness ... debuting a new print, broadcast and digital integrated advertising,campaign ... TV and in print,and will be supported by the ...
Cached Medicine News:Health News:'His and Hers' Screening Campaign Offers Unique Valentine's Day Message to Increase Cancer Screenings and Promote Health 2Health News:'His and Hers' Screening Campaign Offers Unique Valentine's Day Message to Increase Cancer Screenings and Promote Health 3Health News:Seal Shield Ships New SILVER SEAL(TM) Washable, Antimicrobial Keyboard 2Health News:Healthcentral's Healthcare08 Site, an Interactive Health Care Issues Tool, Featured on washingtonpost.com 2Health News:An Event Added to Celebrate and Empower North Carolina Women 2Health News:ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board 2Health News:Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site 2Health News:Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site 3
Available in Purple, orange, dark blue, yellow, gray, royal blue, green and light blue colors....
Icefire has ice crystals on the top of a cool blue iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Medicine Products: